A report from the inspector general of HHS examines the latest trends since several biosimilar versions of Humira were ...

AbbVie claimed FDA approval for its JAK inhibitor Rinvoq (upadacitinib) for rheumatoid arthritis on Friday, setting its price just a little below that of its antibody blockbuster Humira.

People with inflammatory diseases, such as rheumatoid arthritis or psoriatic arthritis, may have too much TNF in their bloodstream and joints. Blocking TNF is how Humira works for the conditions ...

AbbVie Inc’s (NYSE:ABBV) top-selling arthritis drug, Humira, has managed to retain over 80% of its patients even after facing nine lower-priced rivals in the U.S. over the past year, Reuters ...

But, Roche Holdings AG took the chance with a head-to-head study it financed pitting its rheumatoid arthritis treatment Actemra against the market-leader Humira, Abbott Laboratories' blockbuster.

Sanofi’s development of an oral spin on Humira’s mechanism has hit a ... Sanofi expects to publish phase 2 data on balinatunfib in rheumatoid arthritis in the second half of 2025.